Literature DB >> 17412313

The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases.

Maurizio Minetti1, Luciano Agati, Walter Malorni.   

Abstract

Erythrocytes are peculiar cells aimed at the delivery of oxygen and nitric oxide to the periphery and carbon dioxide to the lungs. In addition, they also exert, under physiological conditions, a scavenging activity towards reactive oxygen and nitrogen species often over-produced in morbidity states, e.g. in inflamed tissues. Their deformability is essential for their circulation, specifically in small blood vessels, and this is an important pre-requisite for such vascular "antioxidant" functions. On the other hand, if the erythrocyte undergoes changes in its redox status, i.e. is not capable of counteracting the pro-oxidant status of the microenvironment, it becomes a source of reactive species and, consequently, its typical structural and functional features are lost. More importantly, the oxidatively modified red cell increases its aggregability and adhesiveness to the endothelium and to other blood cells, thus contributing to vascular damage. In line with recent data from the literature, erythrocytes can be proposed as bioindicators of progression in chronic or acute diseases characterized, as a hallmark, by oxidative alterations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17412313     DOI: 10.1016/j.cardiores.2007.03.007

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  30 in total

1.  Training increases peroxiredoxin 2 contents in the erythrocytes of overweight/obese men suffering from type 2 diabetes.

Authors:  David Assadi Moghaddam; Anke Heber; Dario Capin; Thorsten Kreutz; David Opitz; Edward Lenzen; Wilhelm Bloch; Klara Brixius; Christian Brinkmann
Journal:  Wien Med Wochenschr       Date:  2011-11

2.  Lipid-peroxidation and peroxiredoxin-overoxidation in the erythrocytes of non-insulin-dependent type 2 diabetic men during acute exercise.

Authors:  Christian Brinkmann; Jenny Blossfeld; Martin Pesch; Bastian Krone; Kathrin Wiesiollek; Dario Capin; Georgina Montiel; Martin Hellmich; Wilhelm Bloch; Klara Brixius
Journal:  Eur J Appl Physiol       Date:  2011-10-18       Impact factor: 3.078

3.  Engineering erythrocytes as a novel carrier for the targeted delivery of the anticancer drug paclitaxel.

Authors:  Gamaleldin I Harisa; Mohamed F Ibrahim; Fars Alanazi; Gamal A Shazly
Journal:  Saudi Pharm J       Date:  2013-01-07       Impact factor: 4.330

4.  Air pollution and circulating biomarkers of oxidative stress.

Authors:  Ralph J Delfino; Norbert Staimer; Nosratola D Vaziri
Journal:  Air Qual Atmos Health       Date:  2011-03-01       Impact factor: 3.763

5.  Comparison of Taste Threshold in Smokers and Non-Smokers Using Electrogustometry and Fungiform Papillae Count: A Case Control Study.

Authors:  Asim Mustafa Khan; Veena Sathya Narayanan; Jaishankar Homberhalli Puttabuddi; Rachita Chengappa; Vijaya Kumara Ambaldhage; Purnachandrarao Naik; Syed Ahmed Raheel
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 6.  Erythrocyte Duffy antigen receptor for chemokines (DARC): diagnostic and therapeutic implications in atherosclerotic cardiovascular disease.

Authors:  Stavros Apostolakis; Georgios K Chalikias; Dimitrios N Tziakas; Stavros Konstantinides
Journal:  Acta Pharmacol Sin       Date:  2011-03-28       Impact factor: 6.150

Review 7.  Influence of Erythrocyte Membrane Stability in Atherosclerosis.

Authors:  Mario da Silva Garrote-Filho; Morun Bernardino-Neto; Nilson Penha-Silva
Journal:  Curr Atheroscler Rep       Date:  2017-04       Impact factor: 5.113

8.  Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure.

Authors:  Larry A Allen; G Michael Felker; Mandeep R Mehra; Jun R Chiong; Stephanie H Dunlap; Jalal K Ghali; Daniel J Lenihan; Ron M Oren; Lynne E Wagoner; Todd A Schwartz; Kirkwood F Adams
Journal:  J Card Fail       Date:  2009-12-29       Impact factor: 5.712

Review 9.  Oxidative Stress in β-Thalassemia.

Authors:  Eitan Fibach; Mutaz Dana
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

10.  Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside.

Authors:  Ana Villegas; Fernando A Gonzalez; Leopoldo Llorente; Santiago Redondo
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.